Postmarketing studies for novel drugs approved by both the FDA and EMA between 2005 and 2010: a cross-sectional study

OBJECTIVES: To characterise postmarketing studies for drugs that were newly approved by the US Food and Drug Administration and the European Medicines Agency. DESIGN AND SETTING: Cross-sectional analysis of postmarketing studies registered in ClinicalTrials.gov until September 2014 for all novel dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeitoun, Jean-David, Ross, Joseph S, Atal, Ignacio, Vivot, Alexandre, Downing, Nicholas S, Baron, Gabriel, Ravaud, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778291/
https://www.ncbi.nlm.nih.gov/pubmed/29273664
http://dx.doi.org/10.1136/bmjopen-2017-018587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778291/
https://www.ncbi.nlm.nih.gov/pubmed/29273664
http://dx.doi.org/10.1136/bmjopen-2017-018587

Ejemplares similares